<DOC>
	<DOCNO>NCT01733069</DOCNO>
	<brief_summary>The objective study establish performance characteristic AC2 ( APTIMA Combo 2 ) Assay PANTHER System sample type clear use TIGRIS DTS ( Direct Tube Sampling ) Systems demonstrate repeatability reproducibility AC2 Assay PANTHER System .</brief_summary>
	<brief_title>Clinical Evaluation APTIMA® COMBO 2® Assay Using PANTHER™ System</brief_title>
	<detailed_description>The result protocol AC2PS-US11-001 ( NCT01733069 ) base sample collect protocol ACTPS-US10-001 ( NCT01358799 ) . The registration NCT01358799 withdrawn sample test protocol ACTPS-US10-001 , instead test protocol register AC2PS-US11-001 ( NCT01733069 ) .</detailed_description>
	<mesh_term>Gonorrhea</mesh_term>
	<criteria>•The subject least 14 year age time inform consent sexually active The subject report symptoms consistent suspect STD ( sexually transmit disease ) abnormal discharge , genital itching , pain/discomfort sexual intercourse urination , and/or low abdominal discomfort . If subject asymptomatic , subject know partner , contact , person confirm suspect STD ( ) , undergo screen evaluation possible STD ( ) , and/or schedule routine exam may include pelvic exam The subject and/or legally authorize representative willing undergo inform consent process prior study participation ( minor need document consent his/her parent legal guardian , unless site IRB ( institutional review board ) approve waiver parental consent minor ) •A potential subject ineligible clinical trial enrollment subject , clinician , medical record report follow : The subject take antibiotic medication within last 21 day The subject underage ( define IRB ( institutional review board ) state law ) , without document consent her/his parent legal guardian ( exception : site IRBapproved waiver parental consent minor ) The subject determine investigator medically unsuitable participation study ( eg , medical history concurrent illness could result unacceptable risk subject ) Concurrent participation clinical study ( y ) may acceptable , approval investigator sponsor .</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>